-The Telegraph Health ministry asks for 15 samples each from five labs and five hospitals in every state every two weeks, which is less than the 5% prescribed for each state The Union health ministry has asked each state to send 150 Covid-positive samples fortnightly for genome sequencing, deviating from the original target set by a national research consortium to genome-sequence 5 per cent of positive cases from all states. The move has...
More »SEARCH RESULT
Total Matching Records found : 56
After three mutant variants, govt. issues fresh set of travel guidelines -Bindu Shajan Perappadan
-The Hindu The U.K., South Africa and Brazil variants have been currently detected in 86, 44 and 15 countries respectively, India being one of them. The government on Thursday issued a fresh set of travel guidelines, with India reporting the presence of U.K., South Africa and Brazil mutant variants of the SARS-CoV-2 which have demonstrated increased transmissibility, as reported by the World Health Organization. All the three have been currently detected in...
More »How co-morbidities make COVID severe -T Jacob John and MS Seshadri
-The Hindu Physicians are confronted with a complex problem that involves multiple organ systems Medical students are taught to classify diseases as either congenital or acquired. Acquired diseases are infectious or inflammatory, nutritional or metabolic, vascular or neoplastic (tumours, benign or malignant). COVID-19 is acquired, infectious/inflammatory. The microbe is SARS-CoV-2. What are co-morbidities and why do they make COVID-19 severe and life-threatening? Chronic nutritional/metabolic diseases start as diabetes, hypertension, metabolic syndrome or obesity....
More »Experts raise questions over ‘hasty’ approval for COVID-19 vaccines -Jacob Koshy
-The Hindu They advise against Covaxin, say there is no proof of efficacy. Several experts have raised concern over the “hasty approval” granted to the COVID-19 vaccines despite the lack of adequate efficacy data. The Central Drugs Standard Control Organisation on Sunday accorded approval for restricted emergency use of the Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute of India (SII), and the indigenously developed vaccine Covaxin of Bharat Biotech. “I’m completely unaware...
More »Do We Really Know Why COVID-19 Spikes In Some Places? -Rukmini S
-IndiaSpend.com Chennai: About 10 months, nine million cases and over 130,000 deaths later, India does not yet know enough about why the SARS-CoV-2 virus that causes COVID-19 affected whom it did, and how it did that. There is wide variation in the spread of COVID-19 between states. Areas with higher population density are expected to have more cases, but varying testing rates could be affecting case detection. While the elderly and those...
More »
